COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor.
-
Authors
-
-
Mjaess, G1
-
Karam, A2
-
Aoun, F3
-
Albisinni, S4
-
Roumeguère, T5
-
1
Urology Department, University Clinics of Brussels, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Hotel-Dieu de France, University of Saint-Joseph, Beirut, Lebanon.
,
(Belgium)
-
2
Hotel-Dieu de France, University of Saint-Joseph, Beirut, Lebanon.
,
(France)
-
3
Hotel-Dieu de France, University of Saint-Joseph, Beirut, Lebanon; Urology Department, Institut Jules-Bordet, Brussels, Belgium.
,
(Belgium)
-
4
Urology Department, University Clinics of Brussels, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
,
(Belgium)
-
5
Urology Department, University Clinics of Brussels, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Urology Department, Institut Jules-Bordet, Brussels, Belgium. Electronic address: [email protected]
,
(Belgium)
- Type
- Published Article
- Journal
-
Progrès en Urologie
- Publisher
-
Elsevier
- Publication Date
-
Sep 01, 2020
- Volume
-
30
- Issue
-
10
- Pages
-
484–487
- Identifiers
-
DOI: 10.1016/j.purol.2020.05.007
-
PMID: 32620366
- Source
-
Medline
- Keywords
-
- Language
-
English
- License
-
Unknown
Abstract
COVID-19 is the pandemic that hit the world starting December 2019. Recent studies and international statistics have shown an increased prevalence, morbidity as well as mortality of this disease in male patients compared to female patients. The aim of this brief communication is to describe the pathophysiology of this sex-discrepancy, based on the infectivity mechanism of the coronavirus including the Angiotensin-Converting Enzyme 2 (ACE2), the Type II transmembrane Serine Protease (TMPRSS2), and the androgen receptor. This could help understand the susceptibility of urological patients, especially those receiving androgen deprivation therapy for prostate cancer, and testosterone replacement therapy. Copyright © 2020 Elsevier Masson SAS. All rights reserved.
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 01/04/2021 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at
https://www.ncbi.nlm.nih.gov/pubmed/32620366
Report this publication